Mirum Pharmaceuticals CEO Christopher Peetz reports sale of $1.8 million in common shares
MIRM•CEO and director Christopher Peetz sold 20,000 Mirum Pharmaceuticals shares at $90 each on November 4, 2026, after exercising options for the same number of shares at $2.936 each.
1. Share transactions
Peetz sold 20,000 common shares at $90 each and exercised employee stock options for 20,000 common shares at $2.936 each on November 4, 2026. After the transactions, he held 206,637 common shares directly and 187,500 indirectly through The Peetz Family Trust. He had 38,487 employee stock options remaining, expiring March 11, 2029.
